Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds LS2 9LU, UK.
Leeds Institute for Data Analytics, University of Leeds, Leeds LS2 9LU, UK.
Eur J Prev Cardiol. 2022 May 25;29(7):1060-1071. doi: 10.1093/eurjpc/zwab160.
To develop a set of quality indicators (QIs) for the evaluation of the care and outcomes for atherosclerotic cardiovascular disease (ASCVD) prevention.
The Quality Indicator Committee of the European Society of Cardiology (ESC) formed the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with Task Force members of the 2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice and the European Association of Preventive Cardiology (EAPC). We followed the ESC methodology for QI development, which involved (i) the identification of the key domains of care for ASCVD prevention by constructing a conceptual framework of care, (ii) the development of candidate QIs by conducting a systematic review of the literature, (iii) the selection of the final set of QIs using a modified Delphi method, and (iv) the evaluation of the feasibility of the developed QIs. In total, 17 main and 14 secondary QIs were selected across six domains of care for ASCVD prevention: (i) structural framework, (ii) risk assessment, (iii) care for people at risk for ASCVD, (iv) care for patients with established ASCVD, (v) patient education and experience, and (vi) outcomes.
We present the 2021 ESC QIs for Cardiovascular Disease Prevention, which have been co-constructed with EAPC using the ESC methodology for QI development. These indicators are supported by evidence from the literature, underpinned by expert consensus and aligned with the 2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice to offer a mechanism for the evaluation of ASCVD prevention care and outcomes.
制定一套用于评估动脉粥样硬化性心血管疾病（ASCVD）预防护理和结局的质量指标（QIs）。
欧洲心脏病学会（ESC）质量指标委员会与 2021 年 ESC 临床实践心血管疾病预防指南工作组以及欧洲预防心脏病学协会（EAPC）的成员合作，成立了心血管疾病预防质量指标工作组，以制定 ASCVD 预防的质量指标。我们遵循 ESC 质量指标开发方法，该方法包括：（i）通过构建护理概念框架，确定 ASCVD 预防护理的关键领域；（ii）通过系统文献回顾，制定候选质量指标；（iii）使用改良德尔菲法选择最终的质量指标集；（iv）评估开发的质量指标的可行性。总共选择了 17 个主要质量指标和 14 个次要质量指标，涵盖 ASCVD 预防护理的六个领域：（i）结构框架；（ii）风险评估；（iii）ASCVD 风险人群的护理；（iv）已确诊 ASCVD 患者的护理；（v）患者教育和体验；以及（vi）结局。
我们提出了 2021 年 ESC 心血管疾病预防质量指标，该指标是与 EAPC 共同使用 ESC 质量指标开发方法制定的。这些指标得到了文献证据的支持，由专家共识支持，并与 2021 年 ESC 临床实践心血管疾病预防指南一致，为评估 ASCVD 预防护理和结局提供了机制。
